MENU
REPL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Replimune Group (REPL) Earnings Date & Reports

Replimune Group Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

REPL is expected to report earnings to fall 76.00% to -73 cents per share on July 31

Replimune Group REPL Stock Earnings Reports
Q2'25
Est.
$-0.74
Q1'25
Missed
by $2.35
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.08
The last earnings report on May 22 showed earnings per share of -306 cents, missing the estimate of -72 cents. With 2.18M shares outstanding, the current market capitalization sits at 692.24M.
View a ticker or compare two or three
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com